See also this year's filing and all EDGAR filings for this company.
PDF Report 0001806952_2023_Lyell_Immunopharma_Inc.pdf
Logs
Graph
Absolute values for 0001806952, Lyell Immunopharma Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 651,295,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 123,023,000 |
| 3 | remainder_Assets | 163,243,000 |
| 4 | LiabilitiesCurrent | 37,028,000 |
| 5 | LiabilitiesNoncurrent | 67,281,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 117,307,000 |
| 9 | ResearchAndDevelopmentExpense | 159,188,000 |
| 10 | remainder_Expenses | -4,754,000 |
| 11 | remainder_Revenues | 84,683,000 |
| 12 | remainder_NetIncome | 3,940,000 |
| 13 | remainder_ComprehensiveNetIncome | -5,976,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 937,561,000 |
| 1 | Liabilities | 104,309,000 |
| 2 | Expenses | 271,741,000 |
| 3 | Revenues | 84,683,000 |
| 4 | StockholdersEquity | 833,252,000 |
| 5 | NetIncome | -183,118,000 |
| 6 | ComprehensiveNetIncome | -186,106,000 |
| 7 | BaseVar | 704,105,000 |
| 8 | EconomicCapitalRatio | 2.39 |
Edgar->Model Mapping
Feature Distribution
Change over Time
